EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Mutational analysis of primary and advanced chordoma tissue using next‐generation sequencing

Josh Chan iD, Joseph K Kendal iD, Zhenfeng Duan iD, Al Ferreira, Alireza Samiei, Scott D Nelson, Arun Singh, Elizabeth L Lord, Brooke Crawford, Nicholas M Bernthal, Francis J Hornicek

Cancer · 15.08.2025 · 131 (16)

DOI: 10.1002/cncr.70033 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, online erschienen am 13.08.2025. Verfasst von Josh Chan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Section of Orthopaedic Surgery, University of Calgary, Calgary, Alberta, Canada. Hauptthemen laut MEDLINE: Chordoma, High-Throughput Nucleotide Sequencing, Mutation, Bone Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chordomas are rare ectodermal bone malignancies derived from transformed notochordal remnants. Histologic variants include conventional (80%–90%), chondroid (5%–15%), and dedifferentiated (2%–8%). Because chordomas are relatively resistant to chemotherapy and radiotherapy, novel targeted agents are needed to expand treatment approaches and improve outcomes. This study analyzes the genomic landscape of chordoma and identifies potential pathogenic and druggable targets.

Methods

Eighty‐six tumor samples derived from chordoma patients treated at Massachusetts General Hospital, University of California, Los Angeles, and the University of Miami were included. Tumor specimens were sent for comprehensive molecular profiling using next‐generation sequencing. The most frequently mutated genes were identified and categorized by subtype, and microsatellite instability and programmed death ligand‐1 (PD‐L1) staining were assessed.

Results

Histologic subtypes included 70 conventional (81.4%), nine chondroid (10.5%), and seven dedifferentiated chordomas (8.1%). The most common mutations were cyclin‐dependent kinase inhibitor 2A/B ( CDKN2A/B ) (28 of 86, 33%), low‐density lipoprotein receptor‐related protein 1B (10 of 86, 12%), polybromo‐1 (9 of 86, 11%), and epidermal growth factor receptor ( EGFR ) (8 of 86, 9%). By subtype, CDKN2A/B mutation was most common in conventional chordoma (24 of 70, 34%), and chondroid chordoma (3 of 9, 33%). CDKN2A/B and EGFR mutations were most common in dedifferentiated chordoma (2/7, 29%). Microsatellite instability was not detected in seven of 69 (10.1%) samples. PD‐L1 staining of tumor and immune cells was scarce, with scores

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChordomaHigh-Throughput Nucleotide SequencingMutationBone NeoplasmsHumansFemaleMaleMiddle AgedAdultAgedDNA Mutational AnalysisMicrosatellite InstabilityYoung AdultAdolescentB7-H1 AntigenAged, 80 and overBiomarkers, TumorChild

Stichwörter der Autor:innen

CDKN2A/BPD‐L1chordomamolecular profilingmutational analysisnext‐generation sequencing

Substanzen

B7-H1 AntigenCD274 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Surgery, Section of Orthopaedic Surgery, University of Calgary, Calgary, Alberta, Canada.
  • Department of Orthopaedic Surgery, University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Orthopedics, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: Josh Chan, Joseph K Kendal, Zhenfeng Duan

Zitieren

APA

Chan, J., Kendal, J. K., Duan, Z., Ferreira, A., Samiei, A., Nelson, S. D., Singh, A., Lord, E. L., Crawford, B., Bernthal, N. M., & Hornicek, F. J. (2025). Mutational analysis of primary and advanced chordoma tissue using next‐generation sequencing. Cancer, 131(16). https://doi.org/10.1002/cncr.70033

Vancouver

Chan J, Kendal JK, Duan Z, Ferreira A, Samiei A, Nelson SD, et al. Mutational analysis of primary and advanced chordoma tissue using next‐generation sequencing. Cancer. 2025;131(16). doi:10.1002/cncr.70033

BibTeX
@article{Chan2025,
  author = {Chan, Josh and Kendal, Joseph K and Duan, Zhenfeng and Ferreira, Al and Samiei, Alireza and Nelson, Scott D and Singh, Arun and Lord, Elizabeth L and Crawford, Brooke and Bernthal, Nicholas M and Hornicek, Francis J},
  title = {Mutational analysis of primary and advanced chordoma tissue using next‐generation sequencing},
  journal = {Cancer},
  year = {2025},
  volume = {131},
  number = {16},
  doi = {10.1002/cncr.70033}
}
Kostenlos starten →